Medical Cannabis products are used all over the world. In Brazil, it began to be used therapeutically in 2014 after it was found that the frequency of seizures, in cases of refractory epilepsies, could be reduced.
The entire process of importing the product, since that time, was evaluated and monitored by Anvisa [Brazilian Health Surveillance Agency]. And it is precisely this regulatory agency that informs us which diseases have received the highest number of approvals for import of Cannabis-derived extracts into Brazil. From time to time, Anvisa publishes an updated grid of the diseases most frequently treated with the product.
The treatment of different types of Epilepsy still prevails in first place, followed by the treatment of cases of autism. Anxiety, depression, and chronic pain are the other diseases for which the prescription numbers have been growing, since many people have been choosing for the use of medicines with much fewer side effects, as is the Medical Cannabis product against certain psychotropic drugs (anxiolytics and antidepressants) and opioids.
Next comes Parkinson’s disease, soft tissue disorders, cancer, Alzheimer’s with some caveat to the data in the scientific literature that states that not all symptoms of these diseases are responsive to the use of Cannabidiol, the featured active ingredient in Medical Cannabis. The list goes on with Multiple Sclerosis, migraine, bipolar disorder, peripheral neuropathy, fibromyalgia, and sleep disorders.
In order not to make a mistake in your treatment, it is important to be under the care of a specialist. Consult a Physician